Linkers: The key elements for the creation of efficient nanotherapeutics

Area of Science:

• Nanomedicine
• Theranostics
• Drug Delivery Systems

Background:

• Conventional treatments show limited efficiency for many disorders, necessitating advanced theranostic strategies.
• Nanomedicine offers promising solutions for hard-to-treat diseases through high-resolution imaging and multifunctional nanoparticles.
• Current nanotherapeutics face challenges like poor efficiency due to design flaws or nonspecific drug release.

Purpose of the Study:

• To review the critical role of linkers in the development of effective nanomedicine and drug delivery systems.
• To emphasize the importance of selective cell targeting and controlled drug release in nanocarrier design.
• To highlight how linkers contribute to stability, high payloads, and targeted delivery of therapeutic agents.

Main Methods:

• Literature review focusing on nanomedicine, drug delivery systems, and theranostic strategies.
• Analysis of the components and functions of linkers within nanocarrier architectures.
• Examination of factors influencing nanotherapeutic efficiency, particularly drug release mechanisms.

Main Results:

• Linkers are essential components in nanocarrier design, influencing stability and drug payload.
• Proper linker incorporation enables targeted drug delivery and controlled release of therapeutic agents.
• Linkers play a critical role in overcoming the limitations of current nanotherapeutics.

Conclusions:

• Linkers are pivotal for enhancing the efficacy of nanomedicine and drug delivery systems.
• Strategic design of linkers is key to achieving selective cell targeting and controlled drug release.
• Further research into linker chemistry can lead to improved theranostic strategies and treatment outcomes.